Trial Profile
A pharmacokinetic and safety study to evaluate drug-drug interactions of pravastatin and rosuvastatin coadministered with Direct Acting Antiviral combination of ABT-450/r, ombitasvir, dasabuvir (3D) and ABT-450/r+ombitasvir (2D)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Sep 2015
Price :
$35
*
At a glance
- Drugs Dasabuvir (Primary) ; Ombitasvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Paritaprevir (Primary) ; Pravastatin (Primary) ; Rosuvastatin (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 16 Sep 2015 New trial record